The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7).
 
Sven Mahner
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Florian Heitz
No Relationships to Disclose
 
Sahar Salehi
No Relationships to Disclose
 
Alexander Reuss
No Relationships to Disclose
 
Frederic Guyon
No Relationships to Disclose
 
Andreas Du Bois
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/Tesaro; Zodiac Pharma
 
Philipp Harter
Honoraria - Abbvie; Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exscientia; GlaxoSmithKline; Karyopharm Therapeutics; Lilly; Mersana; MSD Oncology; MSD Oncology; Roche; Sotio; Stryker; Zai Lab
Consulting or Advisory Role - Abbvie; AstraZeneca; BioNTech SE; Clovis Oncology; Corcept Therapeutics; Eisai; Exscientia; GlaxoSmithKline; Immunogen; Merck; Mersana; Miltenyi Biomedicine; MSD Oncology; Novartis; Roche; Tesaro; Zymeworks
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Immunogen (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Christina Fotopoulou
Honoraria - AstraZeneca; Ethicon/Johnson & Johnson; GlaxoSmithKline; Roche/Genentech
Consulting or Advisory Role - Aptitude Health; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Global Oncology One; Oncoinvent; Roche/Genentech
Research Funding - Myrovlytis Trust
 
Denis Querleu
No Relationships to Disclose
 
Berit Mosgaard
No Relationships to Disclose
 
Bernhard Kraemer
No Relationships to Disclose
 
Francesco Raspagliesi
Honoraria - GlaxoSmithKline; MSD Oncology
Consulting or Advisory Role - AstraZeneca/Merck (Inst)
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Bjoern Lampe
No Relationships to Disclose
 
Alexander Burges
No Relationships to Disclose
 
Barbara Schmalfeldt
No Relationships to Disclose
 
Pauline Wimberger
No Relationships to Disclose
 
Holger Bronger
Honoraria - Abbvie; AstraZeneca; Gilead Sciences; GlaxoSmithKline; MSD Oncology
Speakers' Bureau - Abbvie; AstraZeneca; Gilead Sciences; GlaxoSmithKline
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; GlaxoSmithKline
 
Dennis Chi
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - BioNTech SE; Doximity
Honoraria - AstraZeneca
Consulting or Advisory Role - Biom'up; Verthermia
 
Jalid Sehouli
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Clovis Oncology; Corcept Therapeutics; Daiichi; Eisai; Esteve Pharmaceuticals; Gilead Sciences; GlaxoSmithKline; Hexal; Incyte; Jenapharm; Johnson & Johnson; Kyowa Kirin International; Medtronic Covidien; MSD Oncology; Myriad Pharmaceuticals; Novartis; Oncoinvent; Pfizer; PharmaMar; Phytolife Nutrition; Roche; Vifor Pharma
Consulting or Advisory Role - Alkermes; AstraZeneca; Bayer/Vital; Bristol Myers Squibb; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo; Eisai; GlaxoSmithKline; Immunogen; Ingress Health; Intuitive Surgical; Johnson & Johnson; Karyopharm Therapeutics; Lilly; Merck; MSD Oncology; Mundipharma; Novocure; Oncoinvent; Pfizer; PharmaMar; Roche; Sanofi Aventis GmbH; Seagen; Sobi; Tubulis GmbH
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); IQvia (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); MSD Oncology (Inst); Mural (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG
 
Giovanni Aletti
No Relationships to Disclose